期刊文献+

拉米夫定耐药HBV毒株的RT区序列分析 被引量:3

Analysis of partial RT region sequences of lamivudine-resistant HBV strains from patients with chronic hepatitis B
暂未订购
导出
摘要 目的 分析拉米夫定耐药HBV毒株部分RT区序列 ,以了解RT区YMDD基序之外HBV的变异情况。方法 采用PCR方法对拉米夫定临床耐药患者治疗前及耐药后血清HBV部分RT区序列进行扩增 ,扩增的核苷酸片段覆盖HBVRT的B区~E区及S基因“a”决定簇 ,对PCR产物进行直接测序 ,将HBVRT区核苷酸和推导的氨基酸序列与治疗前 5 0株HBV野毒株序列和Genebank中 77株不同基因型野毒株序列进行比较 ,同时对HBV进行血清分型。结果  60例患者有YMDD变异 ,其中 2 6例为adw亚型 ,占 43 .3 3 % ;3 4例为adr亚型 ,占 5 6.67%。另外 12例患者( 16.67% )未发现YMDD变异。 16例患者出现 11个RT保守区氨基酸变异 (不包括 5 5 0和 5 2 6位氨基酸变异 ) ;2 5例患者出现 19个HBVRT非保守区氨基酸变异。结论 拉米夫定耐药株的氨基酸变异不仅见于RTB区的 5 2 6和C区 5 5 0两个位点 ,B、C区的其他位点、保守区以及RT非保守区也可发生多个变异。 Objective To analyze the partial RT region sequences of lamivudine resistant HBV strains from patients with chronic hepatitis B and to evaluate the amino acid variances outside HBV YMDD motif. Methods 72 patients with chronic hepatitis B treated by lamivudine for over 1 year were included in the study. All the patients had breakthrough of serum HBV DNA levels and ALT flare up and were clinically diagnosed as being lamivudine resistant. Partial RT region sequences of lamivudine resistant HBV strains and pretreatment HBV wild strains were amplified by PCR using specific primers flanking B C regions of RT and “a” determinant of S gene. Nucleotide and predictive amino acid sequences were compared with wild type HBV sequences from pretreatment serum samples and Genebank. Results YMDD mutations occurred in 60 patients with chronic hepatitis B, 26(43.33%) with serotype adw, 34(56.67%) with serotype adr, the rest of the patients (16.67%) had no YMDD mutation. 11 amino acid variances in conserved regions of RT other than variances at amino acid position 550 and 526 were found in 16 patients. An additional 19 amino acid variances in non conserved regions of RT were also detected in 25 patients.Conclusion Lamivudine resistant HBV strains may harbor several amino acid variances, not only in the non conserved regions of RT, but also in the conserved regions outside YMDD motif.
出处 《肝脏》 2003年第2期28-31,共4页 Chinese Hepatology
关键词 拉米夫定 HBV毒株 耐药株 RT区 序列分析 乙型肝炎 YMDD基序变异 Hepatitis B Lamivudine YMDD motif mutation
  • 相关文献

参考文献6

  • 1Yeh CT, Chien RN, Chu CM, et al. Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy. Hepatology, 2000, 31:1318-1326.
  • 2Bock CT, Tillmann HL, Torresi J, et al. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Gastroenterololgy, 2002. 122:264-273.
  • 3Lin X, Yuan ZH, Wu L, et al. A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency. J Virol, 2001, 75:11827-11833.
  • 4Lok A, MeMahon B. chronic hepatitis B. Hepatology, 2001, 34:1225-1241.
  • 5Benhamou Y, Bochet M, Thibauh V, et al. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients. Hepatology, 1999, 30:1302-1306.
  • 6Zoe11ner B, Petersen J, Schroter M, et al. 20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw. Lancet, 2001,357 : 934-935.

同被引文献29

  • 1姚光弼,崔振宇,姚集鲁,张定凤,籍纳新,黄瑛.国产拉米夫定 治疗2200例慢性乙型肝炎的Ⅳ期临床试验[J].中华医学信息导报,2003,18(8):14-15. 被引量:9
  • 2慢性乙型肝炎防治指南[J].肝脏,2005,10(4):348-357. 被引量:272
  • 3侯金林,孙剑.核苷类似物抗乙肝病毒治疗后耐药新认识[J].中华传染病杂志,2006,24(3):145-147. 被引量:24
  • 4Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis, 2002, 2: 395-403.
  • 5Osiowy C, Villeneuve JP, Heathcote EJ, et al. Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2). J Clin Microbiol, 2006, 44:1994-1997.
  • 6Zeng AZ, Deng H, Yang C, et al. Hepatitis B virus genotype-associated variability in antiviral response to adefovir dipivoxil therapy in Chinese Han population. Tohoku J Exp Med, 2008, 216:205-211.
  • 7Locarnini S, Hatzakis A, Heathcote J, et al. Management of antiviral resistance in patients with chronic hepatitis B. Antivir Ther, 2004, 9: 679-693.
  • 8Schildgen O, Helm M, Gerlich W. Nonresponse to adefovir: host or virus dependent? J Clin Virol, 2006, 37: 327-328.
  • 9Wijnholds J, Mol CA, van Deemter L, et al. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci U S A, 2000, 97: 7476- 7481.
  • 10Chou KM, Kukhanova M, Cheng YC. A novel action of human apurinic/apyrimidinic endonuclease: excision of L-configuration deoxyribonucleoside analogs from the 3' termini of DNA. J Biol Chem, 2000, 275: 31009-31015.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部